| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 18 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 2 |
| GO:0031248 | protein acetyltransferase complex | 3 | 2 |
| GO:0031414 | N-terminal protein acetyltransferase complex | 4 | 2 |
| GO:0031415 | NatA complex | 5 | 2 |
| GO:0032991 | protein-containing complex | 1 | 2 |
| GO:0110165 | cellular anatomical entity | 1 | 2 |
| GO:0140535 | intracellular protein-containing complex | 2 | 2 |
| GO:1902493 | acetyltransferase complex | 4 | 2 |
| GO:1902494 | catalytic complex | 2 | 2 |
| GO:1990234 | transferase complex | 3 | 2 |
Related structures:
AlphaFold database: E9ACG0
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006473 | protein acetylation | 6 | 2 |
| GO:0006475 | internal protein amino acid acetylation | 7 | 2 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
| GO:0006996 | organelle organization | 4 | 2 |
| GO:0007062 | sister chromatid cohesion | 3 | 2 |
| GO:0007064 | mitotic sister chromatid cohesion | 4 | 2 |
| GO:0008152 | metabolic process | 1 | 2 |
| GO:0009987 | cellular process | 1 | 2 |
| GO:0016043 | cellular component organization | 3 | 2 |
| GO:0016570 | histone modification | 5 | 2 |
| GO:0016573 | histone acetylation | 6 | 2 |
| GO:0018193 | peptidyl-amino acid modification | 5 | 2 |
| GO:0018205 | peptidyl-lysine modification | 6 | 2 |
| GO:0018393 | internal peptidyl-lysine acetylation | 8 | 2 |
| GO:0018394 | peptidyl-lysine acetylation | 7 | 2 |
| GO:0019538 | protein metabolic process | 3 | 2 |
| GO:0022402 | cell cycle process | 2 | 2 |
| GO:0036211 | protein modification process | 4 | 2 |
| GO:0043170 | macromolecule metabolic process | 3 | 2 |
| GO:0043412 | macromolecule modification | 4 | 2 |
| GO:0043543 | protein acylation | 5 | 2 |
| GO:0044238 | primary metabolic process | 2 | 2 |
| GO:0051276 | chromosome organization | 5 | 2 |
| GO:0071704 | organic substance metabolic process | 2 | 2 |
| GO:0071840 | cellular component organization or biogenesis | 2 | 2 |
| GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
| GO:1903047 | mitotic cell cycle process | 3 | 2 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 11 |
| GO:0008080 | N-acetyltransferase activity | 6 | 2 |
| GO:0016407 | acetyltransferase activity | 5 | 11 |
| GO:0016410 | N-acyltransferase activity | 5 | 2 |
| GO:0016740 | transferase activity | 2 | 11 |
| GO:0016746 | acyltransferase activity | 3 | 11 |
| GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 11 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 79 | 83 | PF00656 | 0.395 |
| CLV_NRD_NRD_1 | 167 | 169 | PF00675 | 0.385 |
| CLV_PCSK_KEX2_1 | 167 | 169 | PF00082 | 0.465 |
| CLV_PCSK_SKI1_1 | 78 | 82 | PF00082 | 0.329 |
| DOC_CYCLIN_yClb1_LxF_4 | 58 | 64 | PF00134 | 0.332 |
| DOC_MAPK_gen_1 | 120 | 128 | PF00069 | 0.297 |
| DOC_MAPK_MEF2A_6 | 120 | 128 | PF00069 | 0.303 |
| DOC_WW_Pin1_4 | 131 | 136 | PF00397 | 0.297 |
| LIG_14-3-3_CanoR_1 | 106 | 112 | PF00244 | 0.352 |
| LIG_14-3-3_CanoR_1 | 52 | 56 | PF00244 | 0.342 |
| LIG_Actin_WH2_2 | 87 | 104 | PF00022 | 0.426 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.509 |
| LIG_FHA_1 | 125 | 131 | PF00498 | 0.375 |
| LIG_FHA_1 | 71 | 77 | PF00498 | 0.253 |
| LIG_FHA_1 | 89 | 95 | PF00498 | 0.271 |
| LIG_FHA_2 | 154 | 160 | PF00498 | 0.417 |
| LIG_FHA_2 | 77 | 83 | PF00498 | 0.273 |
| LIG_GBD_Chelix_1 | 68 | 76 | PF00786 | 0.332 |
| LIG_LIR_Apic_2 | 34 | 39 | PF02991 | 0.338 |
| LIG_LIR_Gen_1 | 152 | 163 | PF02991 | 0.422 |
| LIG_LIR_Gen_1 | 54 | 63 | PF02991 | 0.396 |
| LIG_LIR_Nem_3 | 152 | 158 | PF02991 | 0.426 |
| LIG_LIR_Nem_3 | 44 | 50 | PF02991 | 0.260 |
| LIG_LIR_Nem_3 | 54 | 58 | PF02991 | 0.337 |
| LIG_LIR_Nem_3 | 7 | 13 | PF02991 | 0.493 |
| LIG_LIR_Nem_3 | 96 | 101 | PF02991 | 0.316 |
| LIG_MAD2 | 31 | 39 | PF02301 | 0.383 |
| LIG_SH2_CRK | 36 | 40 | PF00017 | 0.379 |
| LIG_SH2_GRB2like | 46 | 49 | PF00017 | 0.336 |
| LIG_SH2_STAP1 | 42 | 46 | PF00017 | 0.267 |
| LIG_SH2_STAP1 | 5 | 9 | PF00017 | 0.297 |
| LIG_SH2_STAT5 | 155 | 158 | PF00017 | 0.481 |
| LIG_SH2_STAT5 | 36 | 39 | PF00017 | 0.330 |
| LIG_SH2_STAT5 | 42 | 45 | PF00017 | 0.255 |
| LIG_SH2_STAT5 | 50 | 53 | PF00017 | 0.224 |
| LIG_SH2_STAT5 | 88 | 91 | PF00017 | 0.246 |
| LIG_SH3_3 | 129 | 135 | PF00018 | 0.297 |
| LIG_SH3_3 | 167 | 173 | PF00018 | 0.396 |
| LIG_SUMO_SIM_par_1 | 122 | 127 | PF11976 | 0.388 |
| LIG_TRAF2_1 | 4 | 7 | PF00917 | 0.419 |
| MOD_CDK_SPxxK_3 | 131 | 138 | PF00069 | 0.256 |
| MOD_CK2_1 | 51 | 57 | PF00069 | 0.457 |
| MOD_CK2_1 | 78 | 84 | PF00069 | 0.271 |
| MOD_GlcNHglycan | 112 | 115 | PF01048 | 0.358 |
| MOD_LATS_1 | 100 | 106 | PF00433 | 0.281 |
| MOD_N-GLC_1 | 116 | 121 | PF02516 | 0.329 |
| MOD_N-GLC_1 | 21 | 26 | PF02516 | 0.456 |
| MOD_NEK2_1 | 107 | 112 | PF00069 | 0.304 |
| MOD_NEK2_1 | 21 | 26 | PF00069 | 0.456 |
| MOD_NEK2_1 | 68 | 73 | PF00069 | 0.267 |
| MOD_NEK2_1 | 76 | 81 | PF00069 | 0.307 |
| MOD_NEK2_2 | 70 | 75 | PF00069 | 0.253 |
| MOD_PKA_2 | 51 | 57 | PF00069 | 0.365 |
| MOD_Plk_1 | 21 | 27 | PF00069 | 0.411 |
| MOD_Plk_4 | 107 | 113 | PF00069 | 0.288 |
| MOD_Plk_4 | 42 | 48 | PF00069 | 0.311 |
| MOD_ProDKin_1 | 131 | 137 | PF00069 | 0.297 |
| MOD_SUMO_rev_2 | 2 | 10 | PF00179 | 0.447 |
| TRG_DiLeu_BaEn_1 | 146 | 151 | PF01217 | 0.457 |
| TRG_DiLeu_BaLyEn_6 | 103 | 108 | PF01217 | 0.273 |
| TRG_ENDOCYTIC_2 | 140 | 143 | PF00928 | 0.253 |
| TRG_ENDOCYTIC_2 | 155 | 158 | PF00928 | 0.332 |
| TRG_ENDOCYTIC_2 | 64 | 67 | PF00928 | 0.356 |
| TRG_ENDOCYTIC_2 | 98 | 101 | PF00928 | 0.253 |
| TRG_ER_diArg_1 | 120 | 123 | PF00400 | 0.388 |
| TRG_ER_diArg_1 | 166 | 168 | PF00400 | 0.443 |
| TRG_ER_diLys_1 | 179 | 182 | PF00400 | 0.657 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P4L1 | Leptomonas seymouri | 78% | 100% |
| A0A0S4JJ81 | Bodo saltans | 48% | 100% |
| A0A1X0P8P4 | Trypanosomatidae | 56% | 88% |
| A0A422N7F8 | Trypanosoma rangeli | 55% | 90% |
| A0A451EJL8 | Leishmania donovani | 98% | 100% |
| A3KPA3 | Danio rerio | 27% | 75% |
| A4H3I5 | Leishmania braziliensis | 93% | 100% |
| A8E5V7 | Xenopus tropicalis | 27% | 75% |
| D0A220 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 53% | 89% |
| E9AG32 | Leishmania infantum | 98% | 100% |
| E9AJP8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
| Q0IIJ0 | Bos taurus | 32% | 100% |
| Q17QK9 | Bos taurus | 26% | 75% |
| Q3MHC1 | Rattus norvegicus | 26% | 75% |
| Q5RF28 | Pongo abelii | 32% | 100% |
| Q5XGA9 | Xenopus tropicalis | 34% | 100% |
| Q6DBY2 | Danio rerio | 33% | 100% |
| Q6GP53 | Xenopus laevis | 34% | 100% |
| Q6PGB6 | Mus musculus | 32% | 100% |
| Q9DBU2 | Mus musculus | 26% | 75% |
| Q9GZZ1 | Homo sapiens | 32% | 100% |
| Q9H7X0 | Homo sapiens | 26% | 75% |
| Q9NHD5 | Drosophila melanogaster | 33% | 99% |